| Drug Name |
Dopamine hydrochloride |
| Drug ID |
BADD_D00709 |
| Description |
One of the catecholamine neurotransmitters in the brain. It is derived from tyrosine and is the precursor to norepinephrine and epinephrine. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (receptors, dopamine) mediate its action. |
| Indications and Usage |
For the correction of hemodynamic imbalances present in the shock syndrome due to myocardial infarction, trauma, endotoxic septicemia, open-heart surgery, renal failure, and chronic cardiac decompensation as in congestive failure |
| Marketing Status |
approved |
| ATC Code |
C01CA04 |
| DrugBank ID |
DB00988
|
| KEGG ID |
D00633
|
| MeSH ID |
D004298
|
| PubChem ID |
65340
|
| TTD Drug ID |
D0T7OW
|
| NDC Product Code |
43742-1281; 0338-1009; 0143-9252; 51662-1489; 0338-1005; 0143-9254; 0338-1007; 0404-9982; 71872-7066; 0143-9255; 0404-9981; 0409-9104; 51662-1490; 0409-5820; 65724-4500; 0143-9253; 43857-0412; 51662-1316; 43857-0279 |
| UNII |
7L3E358N9L
|
| Synonyms |
Dopamine | 4-(2-Aminoethyl)-1,2-benzenediol | Hydroxytyramine | 3,4-Dihydroxyphenethylamine | 3,4 Dihydroxyphenethylamine | Dopamine Hydrochloride | Hydrochloride, Dopamine | Intropin |
